These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32512236)

  • 21. Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey.
    Ece G; Samlioglu P; Atalay S; Kose S
    Infez Med; 2014 Mar; 22(1):36-40. PubMed ID: 24651089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of methods for the detection of in vitro synergy in multidrug-resistant gram-negative bacteria.
    Gaudereto JJ; Neto LVP; Leite GC; Espinoza EPS; Martins RCR; Villas Boa Prado G; Rossi F; Guimarães T; Levin AS; Costa SF
    BMC Microbiol; 2020 Apr; 20(1):97. PubMed ID: 32299353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
    Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
    Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Housefly (Musca domestica) and Blow Fly (Protophormia terraenovae) as Vectors of Bacteria Carrying Colistin Resistance Genes.
    Zhang J; Wang J; Chen L; Yassin AK; Kelly P; Butaye P; Li J; Gong J; Cattley R; Qi K; Wang C
    Appl Environ Microbiol; 2018 Jan; 84(1):. PubMed ID: 29030447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flavomycin restores colistin susceptibility in multidrug-resistant Gram-negative bacteria.
    Huang Y; Zhu Y; Yue H-Y; Liu Y-Y; Deng L-M; Lv L; Wang C; Yang J; Liu J-H
    mSystems; 2024 Jun; 9(6):e0010924. PubMed ID: 38695565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmid-mediated mcr-1 gene in Acinetobacter baumannii and Pseudomonas aeruginosa: first report from Pakistan.
    Hameed F; Khan MA; Muhammad H; Sarwar T; Bilal H; Rehman TU
    Rev Soc Bras Med Trop; 2019 Sep; 52():e20190237. PubMed ID: 31508785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens.
    Phee L; Hornsey M; Wareham DW
    Eur J Clin Microbiol Infect Dis; 2013 Oct; 32(10):1291-4. PubMed ID: 23609511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
    Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
    Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Efflux Pump Inhibitors on Colistin Resistance in Multidrug-Resistant Gram-Negative Bacteria.
    Ni W; Li Y; Guan J; Zhao J; Cui J; Wang R; Liu Y
    Antimicrob Agents Chemother; 2016 May; 60(5):3215-8. PubMed ID: 26953203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid screening of colistin-resistant Escherichia coli, Acinetobacter baumannii and Pseudomonas aeruginosa by the use of Raman spectroscopy and hierarchical cluster analysis.
    Lin Z; Zhao X; Huang J; Liu W; Zheng Y; Yang X; Zhang Y; Lamy de la Chapelle M; Fu W
    Analyst; 2019 Apr; 144(8):2803-2810. PubMed ID: 30882113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic activity between colistin and the ionic liquids 1-methyl-3-dodecylimidazolium bromide, 1-dodecyl-1-methylpyrrolidinium bromide, or 1-dodecyl-1-methylpiperidinium bromide against Gram-negative bacteria.
    Florio W; Rizzato C; Becherini S; Guazzelli L; D'Andrea F; Lupetti A
    J Glob Antimicrob Resist; 2020 Jun; 21():99-104. PubMed ID: 32298808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
    Okdah L; Le Page S; Olaitan AO; Dubourg G; Hadjadj L; Rolain JM
    Int J Antimicrob Agents; 2018 May; 51(5):775-783. PubMed ID: 29421171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens.
    Blasco L; Ambroa A; Trastoy R; Bleriot I; Moscoso M; Fernández-Garcia L; Perez-Nadales E; Fernández-Cuenca F; Torre-Cisneros J; Oteo-Iglesias J; Oliver A; Canton R; Kidd T; Navarro F; Miró E; Pascual A; Bou G; Martínez-Martínez L; Tomas M
    Sci Rep; 2020 Apr; 10(1):7163. PubMed ID: 32346029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic Potentiation in Multidrug-Resistant Gram-Negative Pathogenic Bacteria by a Synthetic Peptidomimetic.
    Mood EH; Goltermann L; Brolin C; Cavaco LM; Nejad AJ; Yavari N; Frederiksen N; Franzyk H; Nielsen PE
    ACS Infect Dis; 2021 Aug; 7(8):2152-2163. PubMed ID: 34227804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting the Molecular Mechanism of Colistin Resistance in
    Li J; Beuerman R; Verma CS
    J Chem Inf Model; 2020 Oct; 60(10):4975-4984. PubMed ID: 33017152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens.
    Nguyen HT; Venter H; Veltman T; Williams R; O'Donovan LA; Russell CC; McCluskey A; Page SW; Ogunniyi AD; Trott DJ
    Int J Antimicrob Agents; 2021 May; 57(5):106323. PubMed ID: 33746046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colistin: an update on the antibiotic of the 21st century.
    Biswas S; Brunel JM; Dubus JC; Reynaud-Gaubert M; Rolain JM
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):917-34. PubMed ID: 23030331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.